11: MOLECULAR MECHANISM OF ADIPOGENIC CONVERSION OF SKELETAL MUSCLE STEM CELLS

$181,479P20FY2011RRNIH

Mainehealth, Portland ME

Investigators

Linked publications & trials

Paper 27638773 Paper 27216148 Paper 26148471 Paper 24484870 Paper 24127237 Paper 23553822 Paper 23056600 Paper 22826323 Paper 22808010 Paper 22508938 Paper 22379615 Paper 22374871 Paper 22253704 Paper 22142492 Paper 22128029 Paper 22099018 Paper 22082366 Paper 22074556 Paper 22046312 Paper 22034063 Paper 22031548 Paper 22015065 Paper 22006816 Paper 21998026 Paper 21982879 Paper 21945409 Paper 21854880 Paper 21789165 Paper 21769775 Paper 21685392 Paper 21557454 Paper 21540822 Paper 21483770 Paper 21444673 Paper 21302306 Paper 21252233 Paper 21237142 Paper 21122105 Paper 20979627 Paper 20810925 Paper 20703494 Paper 20657597 Paper 20564361 Paper 20506197 Paper 20459789 Paper 20368328 Paper 20360471 Paper 20100315 Paper 20032500 Paper 19950207 Paper 19937275 Paper 19795517 Paper 19793891 Paper 19705428 Paper 19535568 Paper 19435904 Paper 19357253 Paper 19339244 Paper 19268530 Paper 19264917 Paper 19238173 Paper 19100679 Paper 18854306 Paper 18815218 Paper 18688026 Paper 18617694 Paper 18535204 Paper 18476819 Paper 18471809 Paper 18467647 Paper 18351675 Paper 18349318 Paper 17979183 Paper 17936743 Paper 17904116 Paper 17898542 Paper 17761753 Paper 17700707 Paper 17675579 Paper 17662915 Paper 17647265 Paper 17628518 Paper 17548578 Paper 17403918 Paper 17322871 Paper 17253625 Paper 17154359 Paper 17138661 Paper 17129766 Paper 17038674 Paper 17035101 Paper 16953280 Paper 16952017 Paper 16705093 Paper 16678498 Paper 16543246 Paper 16524748 Paper 16511603 Paper 16502419 Paper 16332976

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Both myogenic and adipogenic cells are generally considered to be derived from the common progenitors. Satellite cells from muscle are differentiated into adipocytes in culture. In addition to satellite cells, PDGF[unreadable]-positive interstitial cells in adult skeletal muscle also showed a strong adipogenic potential. To clinically control intramuscular fat mass increase in obese condition and skeletal muscle diseases, it is important to identify the signaling molecules and their molecular mechanisms by which ectopic adipogenic cells are derived from multipotent stem and progenitor cells. We discovered that Wnt signaling activators, R-spondins, are expressed during myogenic differentiation and regeneration. Rspo induced expression of myogenic determination factor Myf5 and downregulated adipogenic factor C/EBP[unreadable] expression in myogenic progenitor cells, suggesting its inhibitory function in adipogenesis. Furthermore, Follistatin, an antagonist of proadipogenic Myostatin, was also increased in the same cells. We hypothesize that R-spondin is a key regulator for positively regulating myogenic commitment of myogenic stem/progenitor cells, but preventing aberrant adipogenesis by inhibiting Myostatin signaling. Two specific aims are proposed to test this hypothesis: 1) to determine how R-spondin regulates Myostatin signaling and adipogenic differentiation;2) to determine how Rspo2 overexpression in skeletal muscle regulates IMAT mass in obese mice and muscular dystrophic mice. This proposed study is anticipated to uncover the molecular mechanisms by which decision between adipogenic and myogenic fates is regulated and may identify the therapeutic targets that can control adipogenesis and obesity.

View original record on NIH RePORTER →